Produktbild: Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy: Part A

Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy: Part A

Aus der Reihe Advances in Immunology

119,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

18.06.2025

Herausgeber

Arun Kumar Singh + weitere

Verlag

Elsevier Science & Technology

Maße (B/H)

15,2/22,8 cm

Gewicht

470 g

Sprache

Englisch

ISBN

978-0-443-34495-4

Beschreibung

Portrait

Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran , India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies.

Dr. Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Gwalior. He has over 20 years of teaching and research experience in pharmaceutics, with particular expertise in novel drug delivery systems, localized and targeted drug delivery, and nanocarrier-based therapeutics for disease. His formulations and controlled delivery approaches are aimed at improving therapeutic outcomes. Dr. Mishra has supervised postgraduate and doctoral research scholars, has contributed widely to academic literature through research publications, books, and book chapters with leading international publishers. He has won several awards including Outstanding Scientist Award, and Distinguished Professor Award. He is associated with innovation in pharmaceutical sciences through patented research contributions. Over the course of his career, he has received several academic and scientific recognitions for his contributions to teaching, and research. He has been recognized internationally for his research impact and scholarly contributions.

Dr. Sumel Ashique has been working as an assistant professor at the Department of Pharmaceutical Technology, School of Health and Medical Sciences, Adamas University, West Bengal, India. He has 5 years of teaching experience. He has achieved 100+ publications in international and national accredited reputed journals. He has expertise in drug delivery, nanotechnology, and targeted treatment strategies. Recently, he was honored to be in the World's Top 2% Scientists by prestigious Stanford University, CA, United States, and Elsevier in 2025.

Dr. Pranav Kumar Prabhakar is currently working as a Professor and Head at Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India. He is among the World's Top 2% Scientists (list published by Stanford University, USA, 2021, 2022, 2023, 2024, and 2025). He completed his PhD in Biotechnology from IIT Madras. His research focuses on elucidating molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders (diabetes) using natural products. Dr. Pranav is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. He serves as an editorial board member and reviewer for many reputed national and international journals. His honors include a travel grant from IIT Madras and the Council for Scientific and Industrial Research (CSIR) to attend ATTD 2009 in Greece, approved by the Department of Science and Technology (DST). He has published over 160+ research articles, authored/edited 24 books, and 48 book chapters, and delivered 9 oral and poster presentations at scientific meetings.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

18.06.2025

Herausgeber

Verlag

Elsevier Science & Technology

Maße (B/H)

15,2/22,8 cm

Gewicht

470 g

Sprache

Englisch

ISBN

978-0-443-34495-4

EU-Ansprechpartner

Zeitfracht Medien GmbH
Ferdinand-Jühlke-Straße 7
99095 Erfurt
DE
produktsicherheit@zeitfracht.de

Herstelleradresse

Elsevier Science & Technology
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Ein neues Kapitel für Ihre Bücher

Ein neues Kapitel für Ihre Bücher

Schenken Sie Ihren alten Schätzen ein zweites Leben und erhalten dafür eine Thalia Geschenkkarte.

Jetzt verkaufen
Jetzt verkaufen

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy: Part A
  • 1. DNA and mRNA vaccines: Significant therapeutic approach against cancer management

    Aniruddha Sen, Vijay Singh, Sumel Ashique, Jagriti, Sombuddha Biswas, Anas Islam,

    Iman Ehsan, and Naheed Mojgani

    2. Nucleic acid delivery as a therapeutic approach for cancer immunotherapy

    Kashish Wilson, Garima, and Meenakshi Dhanawat

    3. Plasmid DNA and mRNA Delivery: Approaches and Challenges

    Arun Kumar Singh, Karan Goel, and Meenakshi Dhanawat

    4. Viral & non-viral delivery of mRNA against cancer

    Ece Guler, Humeyra Betul Yekeler, Muhammet Emin Cam, and Burcu Uner

    5. Progress in modifying and elivering mRNA therapies for cancer immunotherapy

    Karan Goel, Isha Chawla, Garima, Meenakshi Dhanawat, and Pramila Chaubey

    6. mRNA-based cancer vaccines: A novel approach to melanoma treatment

    Pranav Kumar Prabhakar, Tarun Kumar, Upadhyaya, and

    Sanjeev Kumar Sahu

    7. Therapeutic mRNAs for cancer immunotherapy: From structure to delivery

    Monika Vishwakarma, Wasim Akram, and Tanweer Haider